A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing (Q83964376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

11

Flossie Wong-Staal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Ning Ke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Demin Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jon E Chatterton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Guohong Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

John Chionis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jing Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Lindsey Tsugawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Rebecca Lynn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Dehua Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Bernd Meyhack

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Qi-Xiang Li

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

2726-2734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

What's wrong with our cancer models?

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Development of a tightly regulated U6 promoter for shRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Inducible shRNA expression for application in a prostate cancer mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Inducible, reversible, and stable RNA interference in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Establishment of conditional vectors for hairpin siRNA knockdowns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Adenovirus vector-mediated doxycycline-inducible RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Identification of cellular cofactors for human immunodeficiency virus replication via a ribozyme-based genomics approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

The TOR pathway: a target for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Mammalian target of rapamycin inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Targeting the molecular target of rapamycin (mTOR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

One-week 96-well soft agar growth assay for cancer target validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Doxycycline and other tetracyclines in the treatment of bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.001

10.1016/J.YEXCR.2006.05.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16765945%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference